Article
A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome
18 Nov 2019
Abstract excerpt
Metabolic syndrome is a pathological condition characterized by obesity, hyperglycemia, hypertension, elevated levels of triglycerides and low levels of high-density lipoprotein cholesterol that increase cardiovascular disease risk and type 2 diabetes. Although numerous predisposing genetic risk factors have been identified, the biological mechanisms underlying this complex phenotype are not fully elucidated....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
